CCM
EDIT icon

Cupps Capital Management’s Editas Medicine EDIT Stock Holding History

Cupps Capital Management’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-2,185
Closed -$75K – 173
2016
Q1 		$75K Buy
+2,185
New +$57.4K 0.01% 164

Other funds holding EDIT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FVFIGP
Flagship Ventures Fund IV General Partner Cambridge, Massachusetts $585M AUM
PVMCV
Polaris Venture Management Co VI Boston, Massachusetts $43.1M AUM 78.12% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return

Cupps Capital Management's EDIT Position: Q2 2016 in Review

Cupps Capital Management sold out of Editas Medicine (EDIT) in Q2 2016, closing a stake of 2,185 shares — an estimated $75K sold.

Cupps Capital Management first reported a position in EDIT in Q1 2016 and held it in 1 quarter. The position peaked at $75K in Q1 2016. 68 funds tracked by Wall St. Rank hold EDIT as of Q2 2016.

  • Cupps Capital Management reported no remaining Editas Medicine position as of Q2 2016 after selling out during the quarter.
  • Cupps Capital Management sold 2,185 Editas Medicine shares in Q2 2016, an estimated $75K.
  • Cupps Capital Management first reported a position in Editas Medicine in Q1 2016 and held it in 1 quarter.
  • Cupps Capital Management's Editas Medicine position peaked at $75K in Q1 2016.
  • 68 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2016.

Based on Cupps Capital Management's 13F filing for Q2 2016, filed 12 Aug 2016.